NT-proBNP Levels Following IVIG Treatment of Multisystem Inflammatory Syndrome in Children | Citedby Results | Hospital Pediatrics | American Academy of Pediatrics

Skip to Main Content

Skip Nav Destination

NT-proBNP Levels Following IVIG Treatment of Multisystem Inflammatory Syndrome in Children

Hosp Pediatr (2022) 12 (7): e261–e265.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions

Kamila Maria Ludwikowska
Monika Tokarczyk
Bartłomiej Paleczny
Paweł Tracewski
Leszek Szenborn
Jacek Kusa

International Journal of Molecular Sciences (2024) 25 (16): 8781.

Clinical Predictors of Subacute Myocardial Dysfunction in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19

Daniel McAree
Amanda Hauck
Jennifer Arzu
Michael Carr
Jennifer Acevedo
Ami B. Patel
Nazia Husain

Pediatric Cardiology (2024) 45 (4): 876.

NT-proBNP course during MIS-C post-COVID-19: an observational study

Saïd Bichali
Naïm Ouldali
François Godart
Patrice Maboudou
Ali Houeijeh
Stéphane Leteurtre

European Journal of Pediatrics (2024) 183 (4): 1667.

Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19

Diego Estrada-Luna
Elizabeth Carreón-Torres
Susana González-Reyes
María Fernanda Martínez-Salazar
María Araceli Ortiz-Rodríguez
Esther Ramírez-Moreno
José Arias-Rico
Angélica Saraí Jiménez-Osorio

Life (2022) 12 (10): 1652.